Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    16957147 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
Condition: Percutaneous Coronary Intervention
Intervention: Drug: Enoxaparin sodium
2 Recruiting Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)
Conditions: Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: Enoxaparin (Staged-dose PCI Group);   Drug: Enoxaparin (Single-dose PCI Group);   Drug: Enoxaparin (High-dose Group);   Drug: Enoxaparin (Standard-dose Group)

Study has passed its completion date and status has not been verified in more than two years.